
Memary-Plus 5mg/10mg Tablet
Marketer
Force India Pharma
Salt Composition
Donepezil (5mg) + Memantine (10mg)
Overview Memary-Plus 5mg/10mg Tablet
CogniMax 5mg/10mg tablets are a prescription medication for managing Alzheimer's disease. This treatment helps mitigate the advancement of moderate to severe Alzheimer's by enhancing cognitive function and memory. The medication boosts levels of a neurotransmitter crucial for nerve signal transmission. CogniMax 5mg/10mg tablets may be administered with or without food; however, taking them with food might lessen stomach discomfort. For consistent blood levels, consistent daily dosing is recommended. Avoid missed doses, but if one is missed, take it as soon as recalled. Complete the prescribed course, even with improvement, and avoid abrupt cessation. Potential side effects include nausea, vomiting, appetite loss, tiredness, and headache. Dizziness and drowsiness are also possible, so avoid tasks requiring alertness until the medication's effects are known. Maintain adequate hydration due to potential diarrhea. Prior to use, disclose any history of heart conditions, stomach ulcers, epilepsy, or asthma. Inform your physician of all other medications you're taking, as interactions are possible. Disclose pregnancy, pregnancy plans, or breastfeeding.
Uses of Memary-Plus 5mg/10mg Tablet
Senile dementia of the Alzheimer type
Major Benefits of Memary-Plus 5mg/10mg Tablet:
Consume Memary-Plus 5mg/10mg tablets precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, although consistent daily timing is recommended.
Common Side effects of Memary-Plus 5mg/10mg Tablet:
- Nausea
- Vomiting
- Loss of appetite
- Diarrhea
- Headache
- Dizziness
- Insomnia (difficulty in sleeping)
- Fatigue
- Muscle cramp
How to use Memary-Plus 5mg/10mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Memary-Plus 5mg/10mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Memary-Plus 5mg/10mg Tablet works:
Combiflex AD 5mg/10mg tablets combine donepezil and memantine to manage Alzheimer's disease symptoms. Donepezil, a cholinesterase inhibitor, and memantine, an NMDA receptor antagonist, work synergistically to regulate neurotransmitter balance and enhance neuronal communication.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Memary-Plus 5mg/10mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Memary-Plus 5mg/10mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on Memary-Plus 5mg/10mg Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Driving ability may be impaired by the use of Memary-Plus 5mg/10mg tablets, which can produce adverse reactions.
KidneySAFE IF PRESCRIBED
The use of Memary-Plus 5mg/10mg tablets in individuals with kidney disease appears to pose minimal risk. Preliminary findings indicate that dosage modification may be unnecessary; however, medical advice is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Memary-Plus 5mg/10mg tablets. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Memary-Plus 5mg/10mg Tablet :
Should you forget to take your Memary-Plus 5mg/10mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Memary-Plus 5mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience |
